The mutation in Factor V Leiden alters the normal clotting process. Normally, activated protein C (APC) plays a critical role in regulating blood clotting by inactivating Factor V. However, in individuals with Factor V Leiden, the mutated Factor V is resistant to APC, leading to prolonged clotting activity and an increased risk of thrombosis.
